Camaisa Allan

Camaisa Allan is listed in filings as Director at Calidi Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including sale activity. Recent filings connect the profile to Calidi Biotherapeutics, Inc. (CLDI). The current snapshot covers public activity from Jun 20, 2024 to Dec 16, 2025. Reported amounts are shown as $1.2K to $80.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.